SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-008938
Filing Date
2023-05-10
Accepted
2023-05-09 20:46:49
Documents
81
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q ntra-20230331x10q.htm   iXBRL 10-Q 1867072
2 EX-10.1 ntra-20230331xex10d1.htm EX-10.1 25928
3 EX-31.1 ntra-20230331xex31d1.htm EX-31.1 13853
4 EX-31.2 ntra-20230331xex31d2.htm EX-31.2 14892
5 EX-32.1 ntra-20230331xex32d1.htm EX-32.1 10367
6 EX-32.2 ntra-20230331xex32d2.htm EX-32.2 10650
  Complete submission text file 0001558370-23-008938.txt   9370648

Data Files

Seq Description Document Type Size
7 EX-101.SCH ntra-20230331.xsd EX-101.SCH 57767
8 EX-101.CAL ntra-20230331_cal.xml EX-101.CAL 61081
9 EX-101.DEF ntra-20230331_def.xml EX-101.DEF 310298
10 EX-101.LAB ntra-20230331_lab.xml EX-101.LAB 567496
11 EX-101.PRE ntra-20230331_pre.xml EX-101.PRE 463113
75 EXTRACTED XBRL INSTANCE DOCUMENT ntra-20230331x10q_htm.xml XML 1841506
Mailing Address 13011 MCCALLEN PASS BUILDING A SUITE 100 AUSTIN TX 78753
Business Address 13011 MCCALLEN PASS BUILDING A SUITE 100 AUSTIN TX 78753 650-249-9090
Natera, Inc. (Filer) CIK: 0001604821 (see all company filings)

IRS No.: 010894487 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37478 | Film No.: 23903991
SIC: 8071 Services-Medical Laboratories